Please sign in to follow a disease.

GPA33

Clinical trials for GPA33 explained in plain language.

Never miss a new study

Get alerted when new GPA33 trials appear

Sign up with your email to follow new studies for GPA33, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Completed 1

New radioactive tracer aims to spot colorectal cancer more clearly

Diagnosis Completed

This early-phase trial tested a radioactive tracer called 68Ga-NODAGA-SNA009 in 12 people with colorectal cancer. The tracer targets a protein (GPA33) found on cancer cells and is used with PET scans to see where the cancer is in the body. The main goals were to check safety and …

Matched conditions: GPA33

Early phase 1 • Sponsor: SmartNuclide Biopharma • Aim: Diagnosis

Last updated Jun 27, 2026 12:36 UTC

GPA33

Get alerted when new GPA33 trials appear

New radioactive tracer aims to spot colorectal cancer more clearly